Accord Healthcare Inc. — licence 101566, currently licensed, last inspection rating C (2024-11-26).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02543168 | MICAFUNGIN FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 50 MG | Approved |
| 02560488 | MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTION | BAXTER CORPORATION | Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 50 MG | Approved |
| 02560496 | MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTION | BAXTER CORPORATION | Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 100 MG | Approved |
| 02560518 | MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTION | BAXTER CORPORATION | Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 150 MG | Approved |
| 02547236 | MICAFUNGIN SODIUM FOR INJECTION | JUNO PHARMA CANADA INC. | Powder For Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 100 MG | Marketed |
| 02524961 | MICAFUNGIN SODIUM FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Powder For Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 100 MG | Marketed |
| 02547228 | MICAFUNGIN SODIUM FOR INJECTION | JUNO PHARMA CANADA INC. | Powder For Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 50 MG | Marketed |
| 02524953 | MICAFUNGIN SODIUM FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Powder For Solution | MICAFUNGIN (MICAFUNGIN SODIUM) 50 MG | Marketed |